WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.95 Cr | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.95 Cr |
| Mar2024 | ₹3.95 Cr |
| Mar2023 | ₹3.44 Cr |
| Mar2022 | ₹0.21 Cr |
| Mar2021 | ₹3.59 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.95 Cr | 25.46 | |
| Mar2024 | ₹3.95 Cr | 14.84 | |
| Mar2023 | ₹3.44 Cr | 1,513.62 | |
| Mar2022 | ₹0.21 Cr | -94.06 | |
| Mar2021 | ₹3.59 Cr | - | |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,533.5 Cr | 2.6% | -7.8% | -17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 2.6% |
-7.8% |
-17.8% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses